Tag - pfizer

 
 

PFIZER

Japan Times
JAPAN
Jan 21, 2022
Japan approves Pfizer shot for children age 5 to 11 as omicron spreads
The health ministry has issued fast-track approval to ease the age restriction on receiving the Pfizer vaccine.
Japan Times
WORLD / Science & Health
Jan 16, 2022
The decades of discoveries before the ‘miraculous’ sprint to a vaccine
The breakthroughs behind the vaccines unfolded over decades, little by little, as scientists across the world pursued research in disparate areas.
Japan Times
WORLD / Science & Health
Jan 11, 2022
Singapore breaks down COVID-19 deaths by vaccine, with Moderna seeing lowest rate
While there were some caveats, the findings will likely add to concerns around the efficacy of Sinovac's and Sinopharm Group's shots, which have been widely used in the developing world.
Japan Times
WORLD / Science & Health
Jan 11, 2022
Pfizer starts making vaccine that targets both omicron and the original COVID virus
While research continues, Pfizer will evaluate the new hybrid shot against one specific to omicron and determine which should move forward by March, the firm's CEO has said.
Japan Times
JAPAN / Explainer
Jan 6, 2022
The ins and outs of Japan's COVID-19 booster shot rollout
Japan recommends people receive a different shot for their third doses to the one they received in the initial rollout, but what's the rationale behind that strategy?
Japan Times
WORLD / Science & Health
Dec 18, 2021
Pfizer says pandemic could extend through 2023, studies three-dose vaccine course for children
Pfizer executives said the company believed that by 2024, the disease should be endemic around the globe, meaning it would no longer be a pandemic.
Japan Times
BUSINESS
Dec 17, 2021
Pfizer will dominate $20 billion COVID-19 pill market in 2022, analysis shows
Demand for the medications is poised to outpace supply as COVID-19 spreads around the globe and scientists question how well vaccines and antibody treatments will hold up against omicron.
Japan Times
WORLD
Dec 15, 2021
Pfizer says COVID-19 pill near 90% protective against hospitalization and death
Recent lab data suggests the drug retains its effectiveness against the fast spreading omicron variant of the coronavirus.
Japan Times
BUSINESS
Dec 13, 2021
Billionaire’s bet on Pfizer vaccine for China fails to pay off
Xi Jinping's administration has backed a nationalist agenda on all fronts, including in the fight against the virus.
Japan Times
WORLD
Dec 8, 2021
Pfizer shot provides partial omicron shield, study finds
Researchers in South Africa found omicron reduces virus-blocking antibodies by 40-fold in people who have received two doses of the shot.
Japan Times
COMMENTARY / World
Nov 26, 2021
Did AstraZeneca keep Britain safer from COVID-19 than Europe?
It's suggested that Britain's home-grown jab may be the reason the country is faring better with the latest COVID-19 wave than Europe. Still, is there evidence for that?
Japan Times
WORLD / Science & Health
Nov 16, 2021
Pfizer to allow generic versions of its COVID-19 pill in 95 countries
A Pfizer executive said last week the market for the drug might be up to 150 million people and that many countries might also be interested in buying doses for their strategic reserves.
Japan Times
JAPAN
Nov 10, 2021
Pfizer applies for COVID-19 vaccine approval for kids age 5 to 11 in Japan
If approved by the health ministry, Pfizer's shot will be the first to be administered to children under 11 in Japan.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?